APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tablet Pharmaceutical Excipients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tablet Pharmaceutical Excipients Market Outlook and Growth Opportunities 2026

Report ID 174039490429 December 2025194 pages

Choose your research edition.

Industry ResearchTablet Pharmaceutical Excipients Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Tablet Pharmaceutical Excipients Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Tablet Pharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tablet Pharmaceutical Excipients Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Tablet Pharmaceutical Excipients Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Tablet Pharmaceutical Excipients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tablet Pharmaceutical Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tablet Pharmaceutical Excipients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tablet Pharmaceutical Excipients market include Merck, Lubrizol, Roquette, Protheragen-ING, Meggle-Pharma, Kerry Group, IFF Pharma Solutions, Gattefossé and DFE Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tablet Pharmaceutical Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tablet Pharmaceutical Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tablet Pharmaceutical Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tablet Pharmaceutical Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Tablet Pharmaceutical Excipients Segment by Company

Merck

Lubrizol

Roquette

Protheragen-ING

Meggle-Pharma

Kerry Group

IFF Pharma Solutions

Gattefossé

DFE Pharma

Colorcon

BASF

Abitec

Tablet Pharmaceutical Excipients Segment by Type

Disintegrants

Lubricants

Binders

Colorants

Others

Tablet Pharmaceutical Excipients Segment by Application

Tablets for Oral Use

Tablets for External Use

Tablet Pharmaceutical Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Tablet Pharmaceutical Excipients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tablet Pharmaceutical Excipients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tablet Pharmaceutical Excipients significant trends, drivers, influence factors in global and regions.

6. To analyze Tablet Pharmaceutical Excipients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tablet Pharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tablet Pharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tablet Pharmaceutical Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tablet Pharmaceutical Excipients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tablet Pharmaceutical Excipients industry.

Chapter 3: Detailed analysis of Tablet Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tablet Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tablet Pharmaceutical Excipients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tablet Pharmaceutical Excipients Industry Trends Table 2. Tablet Pharmaceutical Excipients Industry Drivers Table 3. Tablet Pharmaceutical Excipients Industry Opportunities and Challenges Table 4. Tablet Pharmaceutical Excipients Industry Restraints Table 5. Global Tablet Pharmaceutical Excipients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tablet Pharmaceutical Excipients Revenue Share by Company (2021-2026) Table 7. Global Tablet Pharmaceutical Excipients Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Tablet Pharmaceutical Excipients Sales Volume Share by Company (2021-2026) Table 9. Global Tablet Pharmaceutical Excipients Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Tablet Pharmaceutical Excipients Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tablet Pharmaceutical Excipients Key Company Manufacturing Base & Headquarters Table 12. Global Tablet Pharmaceutical Excipients Company, Product Type & Application Table 13. Global Tablet Pharmaceutical Excipients Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tablet Pharmaceutical Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Disintegrants Table 18. Significant Companies of Lubricants Table 19. Significant Companies of Binders Table 20. Significant Companies of Colorants Table 21. Significant Companies of Others Table 22. Global Tablet Pharmaceutical Excipients Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 23. Global Tablet Pharmaceutical Excipients Sales Volume by Type (2021-2026) & (Tons) Table 24. Global Tablet Pharmaceutical Excipients Sales Volume by Type (2027-2032) & (Tons) Table 25. Global Tablet Pharmaceutical Excipients Sales Volume Share by Type (2021-2026) Table 26. Global Tablet Pharmaceutical Excipients Sales Volume Share by Type (2027-2032) Table 27. Global Tablet Pharmaceutical Excipients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Tablet Pharmaceutical Excipients Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Tablet Pharmaceutical Excipients Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Tablet Pharmaceutical Excipients Sales Value Share by Type (2021-2026) Table 31. Global Tablet Pharmaceutical Excipients Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Tablets for Oral Use Table 33. Significant Companies of Tablets for External Use Table 34. Global Tablet Pharmaceutical Excipients Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Tablet Pharmaceutical Excipients Sales Volume by Application (2021-2026) & (Tons) Table 36. Global Tablet Pharmaceutical Excipients Sales Volume by Application (2027-2032) & (Tons) Table 37. Global Tablet Pharmaceutical Excipients Sales Volume Share by Application (2021-2026) Table 38. Global Tablet Pharmaceutical Excipients Sales Volume Share by Application (2027-2032) Table 39. Global Tablet Pharmaceutical Excipients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Tablet Pharmaceutical Excipients Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Tablet Pharmaceutical Excipients Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Tablet Pharmaceutical Excipients Sales Value Share by Application (2021-2026) Table 43. Global Tablet Pharmaceutical Excipients Sales Value Share by Application (2027-2032) Table 44. Global Tablet Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Tablet Pharmaceutical Excipients Sales by Region (2021-2026) & (Tons) Table 46. Global Tablet Pharmaceutical Excipients Sales Market Share by Region (2021-2026) Table 47. Global Tablet Pharmaceutical Excipients Sales by Region (2027-2032) & (Tons) Table 48. Global Tablet Pharmaceutical Excipients Sales Market Share by Region (2027-2032) Table 49. Global Tablet Pharmaceutical Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Tablet Pharmaceutical Excipients Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Tablet Pharmaceutical Excipients Sales Value Share by Region (2021-2026) Table 52. Global Tablet Pharmaceutical Excipients Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Tablet Pharmaceutical Excipients Sales Value Share by Region (2027-2032) Table 54. Global Tablet Pharmaceutical Excipients Market Average Price (US$/Ton) by Region (2021-2026) Table 55. Global Tablet Pharmaceutical Excipients Market Average Price (US$/Ton) by Region (2027-2032) Table 56. Global Tablet Pharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. Global Tablet Pharmaceutical Excipients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Tablet Pharmaceutical Excipients Sales by Country (2021-2026) & (Tons) Table 59. Global Tablet Pharmaceutical Excipients Sales Market Share by Country (2021-2026) Table 60. Global Tablet Pharmaceutical Excipients Sales by Country (2027-2032) & (Tons) Table 61. Global Tablet Pharmaceutical Excipients Sales Market Share by Country (2027-2032) Table 62. Global Tablet Pharmaceutical Excipients Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Tablet Pharmaceutical Excipients Sales Value Market Share by Country (2021-2026) Table 64. Global Tablet Pharmaceutical Excipients Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Tablet Pharmaceutical Excipients Sales Value Market Share by Country (2027-2032) Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Merck Tablet Pharmaceutical Excipients Product Portfolio Table 70. Merck Recent Development Table 71. Lubrizol Company Information Table 72. Lubrizol Business Overview Table 73. Lubrizol Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Lubrizol Tablet Pharmaceutical Excipients Product Portfolio Table 75. Lubrizol Recent Development Table 76. Roquette Company Information Table 77. Roquette Business Overview Table 78. Roquette Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Roquette Tablet Pharmaceutical Excipients Product Portfolio Table 80. Roquette Recent Development Table 81. Protheragen-ING Company Information Table 82. Protheragen-ING Business Overview Table 83. Protheragen-ING Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Protheragen-ING Tablet Pharmaceutical Excipients Product Portfolio Table 85. Protheragen-ING Recent Development Table 86. Meggle-Pharma Company Information Table 87. Meggle-Pharma Business Overview Table 88. Meggle-Pharma Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Meggle-Pharma Tablet Pharmaceutical Excipients Product Portfolio Table 90. Meggle-Pharma Recent Development Table 91. Kerry Group Company Information Table 92. Kerry Group Business Overview Table 93. Kerry Group Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Kerry Group Tablet Pharmaceutical Excipients Product Portfolio Table 95. Kerry Group Recent Development Table 96. IFF Pharma Solutions Company Information Table 97. IFF Pharma Solutions Business Overview Table 98. IFF Pharma Solutions Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. IFF Pharma Solutions Tablet Pharmaceutical Excipients Product Portfolio Table 100. IFF Pharma Solutions Recent Development Table 101. Gattefossé Company Information Table 102. Gattefossé Business Overview Table 103. Gattefossé Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Gattefossé Tablet Pharmaceutical Excipients Product Portfolio Table 105. Gattefossé Recent Development Table 106. DFE Pharma Company Information Table 107. DFE Pharma Business Overview Table 108. DFE Pharma Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. DFE Pharma Tablet Pharmaceutical Excipients Product Portfolio Table 110. DFE Pharma Recent Development Table 111. Colorcon Company Information Table 112. Colorcon Business Overview Table 113. Colorcon Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Colorcon Tablet Pharmaceutical Excipients Product Portfolio Table 115. Colorcon Recent Development Table 116. BASF Company Information Table 117. BASF Business Overview Table 118. BASF Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. BASF Tablet Pharmaceutical Excipients Product Portfolio Table 120. BASF Recent Development Table 121. Abitec Company Information Table 122. Abitec Business Overview Table 123. Abitec Tablet Pharmaceutical Excipients Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Abitec Tablet Pharmaceutical Excipients Product Portfolio Table 125. Abitec Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Tablet Pharmaceutical Excipients Distributors List Table 129. Tablet Pharmaceutical Excipients Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Tablet Pharmaceutical Excipients Product Image Figure 2. Global Tablet Pharmaceutical Excipients Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tablet Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tablet Pharmaceutical Excipients Sales (2021-2032) & (Tons) Figure 5. Global Tablet Pharmaceutical Excipients Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Tablet Pharmaceutical Excipients Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Disintegrants Image Figure 10. Lubricants Image Figure 11. Binders Image Figure 12. Colorants Image Figure 13. Others Image Figure 14. Global Tablet Pharmaceutical Excipients Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Tablet Pharmaceutical Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Tablet Pharmaceutical Excipients Sales Volume Share by Type (2021-2032) Figure 17. Global Tablet Pharmaceutical Excipients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Tablet Pharmaceutical Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Tablet Pharmaceutical Excipients Sales Value Share by Type (2021-2032) Figure 20. Tablets for Oral Use Image Figure 21. Tablets for External Use Image Figure 22. Global Tablet Pharmaceutical Excipients Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Tablet Pharmaceutical Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Tablet Pharmaceutical Excipients Sales Volume Share by Application (2021-2032) Figure 25. Global Tablet Pharmaceutical Excipients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Tablet Pharmaceutical Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Tablet Pharmaceutical Excipients Sales Value Share by Application (2021-2032) Figure 28. Global Tablet Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Tablet Pharmaceutical Excipients Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Tablet Pharmaceutical Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Tablet Pharmaceutical Excipients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Tablet Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 33. North America Tablet Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Tablet Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Tablet Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Tablet Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Tablet Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Tablet Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 39. South America Tablet Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Tablet Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Tablet Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Tablet Pharmaceutical Excipients Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Tablet Pharmaceutical Excipients Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Disintegrants
  • Lubricants
  • Binders
  • Colorants
  • Others
Applications
  • Tablets for Oral Use
  • Tablets for External Use
Companies covered
  • Merck
  • Lubrizol
  • Roquette
  • Protheragen-ING
  • Meggle-Pharma
  • Kerry Group
  • IFF Pharma Solutions
  • Gattefossé
  • DFE Pharma
  • Colorcon
  • BASF
  • Abitec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tablet Pharmaceutical Excipients Sales Value (2021-2032)
  4. 1.2.2 Global Tablet Pharmaceutical Excipients Sales Volume (2021-2032)
  5. 1.2.3 Global Tablet Pharmaceutical Excipients Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tablet Pharmaceutical Excipients Market Dynamics
  1. 2.1 Tablet Pharmaceutical Excipients Industry Trends
  2. 2.2 Tablet Pharmaceutical Excipients Industry Drivers
  3. 2.3 Tablet Pharmaceutical Excipients Industry Opportunities and Challenges
  4. 2.4 Tablet Pharmaceutical Excipients Industry Restraints
3 Tablet Pharmaceutical Excipients Market by Company
  1. 3.1 Global Tablet Pharmaceutical Excipients Company Revenue Ranking in 2025
  2. 3.2 Global Tablet Pharmaceutical Excipients Revenue by Company (2021-2026)
  3. 3.3 Global Tablet Pharmaceutical Excipients Sales Volume by Company (2021-2026)
  4. 3.4 Global Tablet Pharmaceutical Excipients Average Price by Company (2021-2026)
  5. 3.5 Global Tablet Pharmaceutical Excipients Company Ranking (2024-2026)
  6. 3.6 Global Tablet Pharmaceutical Excipients Company Manufacturing Base and Headquarters
  7. 3.7 Global Tablet Pharmaceutical Excipients Company Product Type and Application
  8. 3.8 Global Tablet Pharmaceutical Excipients Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tablet Pharmaceutical Excipients Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tablet Pharmaceutical Excipients Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tablet Pharmaceutical Excipients Market by Type
  1. 4.1 Tablet Pharmaceutical Excipients Type Introduction
  2. 4.1.1 Disintegrants
  3. 4.1.2 Lubricants
  4. 4.1.3 Binders
  5. 4.1.4 Colorants
  6. 4.1.5 Others
  7. 4.2 Global Tablet Pharmaceutical Excipients Sales Volume by Type
  8. 4.2.1 Global Tablet Pharmaceutical Excipients Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Tablet Pharmaceutical Excipients Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Tablet Pharmaceutical Excipients Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Tablet Pharmaceutical Excipients Sales Value by Type
  12. 4.3.1 Global Tablet Pharmaceutical Excipients Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Tablet Pharmaceutical Excipients Sales Value by Type (2021-2032)
  14. 4.3.3 Global Tablet Pharmaceutical Excipients Sales Value Share by Type (2021-2032)
5 Tablet Pharmaceutical Excipients Market by Application
  1. 5.1 Tablet Pharmaceutical Excipients Application Introduction
  2. 5.1.1 Tablets for Oral Use
  3. 5.1.2 Tablets for External Use
  4. 5.2 Global Tablet Pharmaceutical Excipients Sales Volume by Application
  5. 5.2.1 Global Tablet Pharmaceutical Excipients Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Tablet Pharmaceutical Excipients Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Tablet Pharmaceutical Excipients Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Tablet Pharmaceutical Excipients Sales Value by Application
  9. 5.3.1 Global Tablet Pharmaceutical Excipients Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Tablet Pharmaceutical Excipients Sales Value by Application (2021-2032)
  11. 5.3.3 Global Tablet Pharmaceutical Excipients Sales Value Share by Application (2021-2032)
6 Tablet Pharmaceutical Excipients Regional Sales and Value Analysis
  1. 6.1 Global Tablet Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tablet Pharmaceutical Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Tablet Pharmaceutical Excipients Sales by Region: 2021-2026
  4. 6.2.2 Global Tablet Pharmaceutical Excipients Sales by Region (2027-2032)
  5. 6.3 Global Tablet Pharmaceutical Excipients Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tablet Pharmaceutical Excipients Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tablet Pharmaceutical Excipients Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tablet Pharmaceutical Excipients Sales Value by Region (2027-2032)
  9. 6.5 Global Tablet Pharmaceutical Excipients Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tablet Pharmaceutical Excipients Sales Value (2021-2032)
  12. 6.6.2 North America Tablet Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tablet Pharmaceutical Excipients Sales Value (2021-2032)
  15. 6.7.2 Europe Tablet Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tablet Pharmaceutical Excipients Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tablet Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tablet Pharmaceutical Excipients Sales Value (2021-2032)
  21. 6.9.2 South America Tablet Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tablet Pharmaceutical Excipients Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tablet Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
7 Tablet Pharmaceutical Excipients Country-level Sales and Value Analysis
  1. 7.1 Global Tablet Pharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tablet Pharmaceutical Excipients Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tablet Pharmaceutical Excipients Sales by Country (2021-2032)
  4. 7.3.1 Global Tablet Pharmaceutical Excipients Sales by Country (2021-2026)
  5. 7.3.2 Global Tablet Pharmaceutical Excipients Sales by Country (2027-2032)
  6. 7.4 Global Tablet Pharmaceutical Excipients Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tablet Pharmaceutical Excipients Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tablet Pharmaceutical Excipients Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tablet Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tablet Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tablet Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Tablet Pharmaceutical Excipients Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Lubrizol
  8. 8.2.1 Lubrizol Company Information
  9. 8.2.2 Lubrizol Business Overview
  10. 8.2.3 Lubrizol Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lubrizol Tablet Pharmaceutical Excipients Product Portfolio
  12. 8.2.5 Lubrizol Recent Developments
  13. 8.3 Roquette
  14. 8.3.1 Roquette Company Information
  15. 8.3.2 Roquette Business Overview
  16. 8.3.3 Roquette Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Roquette Tablet Pharmaceutical Excipients Product Portfolio
  18. 8.3.5 Roquette Recent Developments
  19. 8.4 Protheragen-ING
  20. 8.4.1 Protheragen-ING Company Information
  21. 8.4.2 Protheragen-ING Business Overview
  22. 8.4.3 Protheragen-ING Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Protheragen-ING Tablet Pharmaceutical Excipients Product Portfolio
  24. 8.4.5 Protheragen-ING Recent Developments
  25. 8.5 Meggle-Pharma
  26. 8.5.1 Meggle-Pharma Company Information
  27. 8.5.2 Meggle-Pharma Business Overview
  28. 8.5.3 Meggle-Pharma Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Meggle-Pharma Tablet Pharmaceutical Excipients Product Portfolio
  30. 8.5.5 Meggle-Pharma Recent Developments
  31. 8.6 Kerry Group
  32. 8.6.1 Kerry Group Company Information
  33. 8.6.2 Kerry Group Business Overview
  34. 8.6.3 Kerry Group Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kerry Group Tablet Pharmaceutical Excipients Product Portfolio
  36. 8.6.5 Kerry Group Recent Developments
  37. 8.7 IFF Pharma Solutions
  38. 8.7.1 IFF Pharma Solutions Company Information
  39. 8.7.2 IFF Pharma Solutions Business Overview
  40. 8.7.3 IFF Pharma Solutions Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 IFF Pharma Solutions Tablet Pharmaceutical Excipients Product Portfolio
  42. 8.7.5 IFF Pharma Solutions Recent Developments
  43. 8.8 Gattefossé
  44. 8.8.1 Gattefossé Company Information
  45. 8.8.2 Gattefossé Business Overview
  46. 8.8.3 Gattefossé Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gattefossé Tablet Pharmaceutical Excipients Product Portfolio
  48. 8.8.5 Gattefossé Recent Developments
  49. 8.9 DFE Pharma
  50. 8.9.1 DFE Pharma Company Information
  51. 8.9.2 DFE Pharma Business Overview
  52. 8.9.3 DFE Pharma Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 DFE Pharma Tablet Pharmaceutical Excipients Product Portfolio
  54. 8.9.5 DFE Pharma Recent Developments
  55. 8.10 Colorcon
  56. 8.10.1 Colorcon Company Information
  57. 8.10.2 Colorcon Business Overview
  58. 8.10.3 Colorcon Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Colorcon Tablet Pharmaceutical Excipients Product Portfolio
  60. 8.10.5 Colorcon Recent Developments
  61. 8.11 BASF
  62. 8.11.1 BASF Company Information
  63. 8.11.2 BASF Business Overview
  64. 8.11.3 BASF Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 BASF Tablet Pharmaceutical Excipients Product Portfolio
  66. 8.11.5 BASF Recent Developments
  67. 8.12 Abitec
  68. 8.12.1 Abitec Company Information
  69. 8.12.2 Abitec Business Overview
  70. 8.12.3 Abitec Tablet Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Abitec Tablet Pharmaceutical Excipients Product Portfolio
  72. 8.12.5 Abitec Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tablet Pharmaceutical Excipients Value Chain Analysis
  2. 9.1.1 Tablet Pharmaceutical Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tablet Pharmaceutical Excipients Sales Mode & Process
  6. 9.2 Tablet Pharmaceutical Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tablet Pharmaceutical Excipients Distributors
  9. 9.2.3 Tablet Pharmaceutical Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst